Infinium Pharmachem (NSE:INFINIUM) Total Operating Expense: ₹226 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:INFINIUM Infinium Pharmachem Ltd NSE:INFINIUM
86 GF Score
Price ₹207.00
GF Value ₹305.81
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Infinium Pharmachem Total Operating Expense?

Infinium Pharmachem NSE:INFINIUM -1.76% 86 Total Operating Expense is ₹226 Mil as of Mar. 2026. GuruFocus rates NSE:INFINIUM with a GF Score™ of 86/100 and a GF Value™ of ₹305.81 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Infinium Pharmachem's Total Operating Expense for the six months ended in Mar. 2026 was ₹109 Mil. Infinium Pharmachem's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹226 Mil.

Infinium Pharmachem Total Operating Expense Related Terms

Infinium Pharmachem Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Infinium Pharmachem's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Infinium Pharmachem Total Operating Expense Chart

Infinium Pharmachem Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Operating Expense
Get a 7-Day Free Trial 128.63 186.97 165.89 249.80 225.71

Infinium Pharmachem Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 88.39 110.23 139.56 116.28 109.43
NSE:INFINIUM
86GF Score
Infinium Pharmachem Ltd NSE:INFINIUM
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Infinium Pharmachem Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹226 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of ₹226 Mil mean?
Infinium Pharmachem (NSE:INFINIUM) has a Total Operating Expense of ₹226 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Infinium Pharmachem and its competitors.
Is Infinium Pharmachem's Total Operating Expense too high?
Infinium Pharmachem's current Total Operating Expense is ₹226 Mil. Overall, Infinium Pharmachem has a GF Score™ of 86/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Infinium Pharmachem's Total Operating Expense compare to DOW?
Infinium Pharmachem's Total Operating Expense of ₹226 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Chemicals company?
A good Total Operating Expense depends on the Chemicals industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Infinium Pharmachem and its competitors. Infinium Pharmachem's current Total Operating Expense is ₹226 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Infinium Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Infinium Pharmachem (NSE:INFINIUM) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹305.81, compared to a current price of ₹207.00 — trading 32.3% below its estimated fair value. The current Total Operating Expense is ₹226 Mil. Infinium Pharmachem's overall GF Score™ is 86/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Infinium Pharmachem (NSE:INFINIUM), the current Total Operating Expense is ₹226 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Infinium Pharmachem (NSE:INFINIUM) Overvalued in 2026?

Based on GuruFocus' analysis, Infinium Pharmachem stock appears to be undervalued. The current stock price of ₹207.00 is trading 32.3% below its estimated GF Value™ of ₹305.81. GuruFocus considers Infinium Pharmachem to be Significantly Undervalued.

Key valuation signals for NSE:INFINIUM:

  • Total Operating Expense: ₹226 Mil
  • GF Value™: ₹305.81 vs. price of ₹207.00 (32.3% below fair value)
  • GF Score™: 86/100 with 2 warning signs

No single metric tells the full story. See the NSE:INFINIUM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Infinium Pharmachem Business Description

Address V.U. Nagar GIDC Road, Near Sardar Patel Statue, Suite 205, Sigma Prime, 2nd Floor, District Anand, Vallabh Vidhyanagar, GJ, IND, 388120
Infinium Pharmachem Ltd is engaged in the business of manufacturing and supplying Iodine, Iodine Derivatives and Active Pharmaceutical Ingredients (APIs). It provides fully integrated customized services from R & D to Commercial scale manufacturing and packaging for its products to the Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals and various other chemicals Industries.
86GF Score

Get the complete analysis for NSE:INFINIUM

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹207.00
Price
₹305.81
GF Value